TELA Bio, Inc. Quarterly Nonoperating Income (Expense) in USD from Q2 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
TELA Bio, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2019 to Q3 2024.
  • TELA Bio, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$1.01M, a 29.8% decline year-over-year.
  • TELA Bio, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$3.48M, a 38.4% decline year-over-year.
  • TELA Bio, Inc. annual Nonoperating Income (Expense) for 2023 was -$2.59M, a 51% increase from 2022.
  • TELA Bio, Inc. annual Nonoperating Income (Expense) for 2022 was -$5.29M, a 38.3% decline from 2021.
  • TELA Bio, Inc. annual Nonoperating Income (Expense) for 2021 was -$3.83M, a 8.7% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$3.48M -$1.01M -$231K -29.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 -$3.25M -$1.03M -$602K -141% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$2.65M -$835K -$62K -8.02% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$2.59M -$612K -$72K -13.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-22
Q3 2023 -$2.52M -$776K +$451K +36.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 -$2.97M -$428K +$2.08M +82.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$5.04M -$773K +$245K +24.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$5.29M -$540K +$425K +44% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-22
Q3 2022 -$5.71M -$1.23M -$178K -17% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$5.54M -$2.5M -$1.56M -165% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$3.98M -$1.02M -$151K -17.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$3.83M -$965K +$78K +7.48% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-22
Q3 2021 -$3.9M -$1.05M -$209K -24.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$3.69M -$944K -$29K -3.17% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$3.67M -$867K -$146K -20.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 -$3.52M -$1.04M Oct 1, 2020 Dec 31, 2020 10-K 2023-03-23
Q3 2020 -$840K -$30K -3.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$915K +$46K +4.79% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$721K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q3 2019 -$810K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$961K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.